IVIM Health vs MedVi: Compare GLP-1 Programs & Pricing
Side-by-side IVIM Health and MedVi: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
IVIM Health and MedVi are two telehealth providers that offer GLP-1–based weight-management programs and peptide-based prescriptions under clinician oversight. This comparison highlights pricing, membership requirements, clinical process, safety notes related to compounded medications, and how each platform manages patient follow-up to help you choose the best fit.
Visit IVIM Health
Explore MedVi
IVIM Health vs MedVi: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| IVIM Health | $99.00 | $149.00 | Free 1st Month Membership (Code: GIFT75) | $75.00 — Yes |
| MedVi | $179.00 | $279.00 | $120 off first month (Code: ) | — No |
IVIM Health vs MedVi: Medical Process & Accessibility
IVIM Health typically emphasizes rapid telehealth intake and expedited clinician review to approve prescriptions, while MedVi focuses on scheduled follow-ups and dose optimization. Both require a medical evaluation by a licensed clinician before any GLP-1 or peptide prescription is issued, and both operate within U.S. telehealth regulations.
IVIM Health vs MedVi: Pricing Comparison
IVIM Health lists semaglutide starting at $99.00 and tirzepatide starting at $149.00. MedVi lists semaglutide from $179.00 and tirzepatide from $279.00. For clarity, the lower price points in this comparison are bolded to show where initial costs may be less.
Promotions differ: IVIM Health advertises a “Free 1st Month Membership” with promo code GIFT75, while MedVi advertises a “$120 off first month” promotion (no code listed). Membership requirements affect total cost: IVIM lists a $75.00 membership fee and indicates membership is required, while MedVi does not require a paid membership. Review the full price breakdown on each provider site before enrolling.
IVIM Health vs MedVi: Clinical Oversight & Support
Both providers connect patients with licensed clinicians for evaluation, prescription decisions, and follow-up. Clinical oversight includes reviewing medical history, assessing contraindications, and monitoring adverse effects. Telehealth care is subject to clinician judgment and state licensing; not every patient is eligible for GLP-1 therapies. If a clinician determines GLP-1 therapy is inappropriate, they will recommend alternatives.
Book a Consultation with IVIM Health
IVIM Health vs MedVi: Medication Quality & Safety
Some telehealth providers dispense compounded GLP-1 products through accredited U.S. pharmacies. Compounded medications are legally prescribed and can be appropriate in certain clinical contexts, but they are not identical to FDA-approved brand formulations (for example, Wegovy® or Mounjaro®). Patients should understand that compounded products may differ in formulation and that branded, FDA-approved medications carry their own labeled indications and evidence base.
All GLP-1 therapies and peptide prescriptions are prescription-only. The clinical team should review potential side effects (nausea, GI upset, pancreatitis risk, and other rare but serious events) and discuss monitoring. Always disclose your full medical history and medications during the telehealth visit.
Learn About Medication Safety at MedVi
IVIM Health vs MedVi: Customer Experience
User reports often highlight different strengths: IVIM Health is commonly noted for affordability and quick onboarding, whereas MedVi receives positive feedback for more structured follow-up and clinician communication. Shipping times, pharmacy partners, and refill processes vary; both providers typically dispatch medication after clinical approval and required screening.
IVIM Health vs MedVi: Final Verdict
Choose IVIM Health if low introductory pricing and a rapid enrollment process are top priorities. Choose MedVi if you prefer a program that emphasizes ongoing dose management and structured clinician engagement. Both are licensed telehealth options that require prescription authorization, and both recommend clinician-led monitoring for safety and effectiveness.
Join IVIM Health
Get Started with MedVi
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Medication availability, pricing, and promotions can change; check each provider’s official site for current details. All GLP-1 and peptide therapies require evaluation by a licensed clinician. Always consult a healthcare professional before starting or changing treatment. GLP1Talks & GLP1Discussions may receive affiliate commissions at no cost to you.